2. To examine the effectiveness and acceptability of different humanistic therapy models (person-centred, gestalt, processexperiential, transactional analysis, existential and non-directive therapies) compared with all other psychological therapy approaches for acute depression.
3. To examine the effectiveness and acceptability of all humanistic therapies compared with different psychological therapy approaches (psychodynamic, behavioural, humanistic, integrative, cognitive-behavioural) for acute depression.
B A C K G R O U N D Description of the condition
Major depression is characterised by persistent low mood and loss of interest in pleasurable activities, accompanied by a range of symptoms including weight loss, insomnia, fatigue, loss of energy, inappropriate guilt, poor concentration and morbid thoughts of death (APA 2000) . Somatic complaints are also a common feature of depression, and people with severe depression may develop psychotic symptoms (APA 2000) . Depression is the third leading cause of disease burden worldwide and is expected to show a rising trend over the next 20 years (WHO 2004; WHO 2008) . A recent European study has estimated the point prevalence of major depression and dysthymia at 3.9% and 1.1% respectively (ESEMeD/MHEDEA 2004) . As the largest source of non-fatal disease burden in the world, accounting for 12% of years lived with disability (Ustun 2004), depression is associated with marked personal, social and economic morbidity, loss of functioning and productivity and creates significant demands on service providers in terms of workload (NICE 2009) . Depression is also associated with a significantly increased risk of mortality (Cuijpers 2002) . The strength of this association, even taking account of confounders such as physical impairment, health-related behaviours and socio-economic factors, has been shown to be comparable to, or greater than, the strength of the association between smoking and mortality (Mykletun 2009).
Description of the intervention
Clinical guidelines recommend pharmacological and psychological interventions, alone or in combination, in the treatment of moderate to severe depression (NICE 2009 ). Antidepressant prescribing has increased dramatically in many Western countries over the last 20 years, mainly with the advent of selective serotonin reuptake inhibitors and newer agents such as venlafaxine. Antidepressants continue to be the mainstay of treatment for depression in health care settings (Ellis 2004 , NICE 2009 ). Whilst antidepressants are of proven efficacy for the acute treatment of depression (Guaiana 2007; Arroll 2009; Cipriani 2009a; Cipriani 2009b; Cipriani 2009c) , adherence rates remain very low (Hunot 2007; van Geffen 2009) , due in part to patients' concerns about side effects and possible dependency (Hunot 2007) . Furthermore, surveys consistently demonstrate patients' preference for psychological therapies over that of antidepressants (Churchill 2000; Riedel-Heller 2005) . Therefore, psychological therapies provide an important alternative intervention for depressive disorders. A diverse range of psychological therapies is now available for the treatment of common mental disorders (Pilgrim 2002) . Psychological therapies may be broadly categorised into four separate philosophical and theoretical schools, comprising psychoanalytic/dynamic (Freud 1949; Klein 1960; Jung 1963) , behavioural (Watson 1924; Skinner 1953; Marks 1981) , humanistic (Maslow 1943; May 1961) and cognitive approaches (Lazarus 1971; Beck 1979) . Each of these four schools contains a number of differing and overlapping psychotherapeutic approaches. Some psychotherapeutic approaches explicitly integrate components from several theoretical schools (e.g. cognitive analytic therapy (Ryle 1990 )), or have been developed to address specific characteristics associated with particular disorders (e.g. interpersonal therapy for depression (Klerman 1984) ). During the first half of the twentieth century, psychology had been dominated by two schools of thought, behaviourism and psychoanalysis. Humanistic psychological therapies were developed in the 1950s and 60s as a protest against the diagnostic and prescriptive approaches characterised by the analytic and behavioural schools (Thorne 2007). These so-called 'third force' psychology approaches (Maslow 1959) brought about a paradigm shift, away from the 'psychological determinism' (the philosophical view that human cognition, behaviour, decision, and action, is causally determined by events, and implying a lack of free will) and towards client choice and responsibility (Pilgrim 2002) . Key psychological therapies considered as humanistic in approach include Gestalt therapy (Perls 1976) , existential therapy (Deurzen 1997), transactional analysis (Berne 1961), person-centred therapy , and process-experiential therapy (a manualised humanistic intervention combining person-centred therapy and emotion-focused therapy) (Greenberg 1998).To date, person-centred therapy remains the most commonly used psychotherapeutic approach in UK health care settings (Stiles 2008 ) (see Types of interventions section for a detailed description of each type of therapy).
How the intervention might work
Humanistic psychological therapies are based on the premise that people are 'self-actualizing', that is, they have an inherent tendency to develop their potential Maslow 1970) . Other defining characteristics of humanistic therapies include the belief that people are self-aware, are free to choose how they will live, are responsible for the choices they make, and are unique entities that need to be understood in the context of their individual experiences and characteristics (Cain 2002) . In clinical practice, manualised or highly specific treatments for psychological disorders are largely avoided by humanistic therapists, on the basis that therapy should be individualised to fit with the personal goals, preferences and values of each client. Whilst contemporary models of humanistic therapies may differ somewhat from a conceptual perspective and in terms of strategies/techniques, all emphasise the 'growth-inducing power' (Cain 2002) of the therapeutic relationship. Therapist 'core conditions' of empathy, genuineness and unconditional positive regard, described by Rogers 1951 as 'the definable climate of facilitative psychological attitudes', are considered as cornerstones of therapy. Creation of an optimal interpersonal environment to facilitate client insight, leading to acceptance, change and personal growth with resulting potential for a reduction in depression symptoms (Cain 2002) . Presenting problems are person rather than disorder-focused, and individuals are treated as experts in their psychological distress. Whilst formal reduction in symptoms is not regarded as a goal in humanistic therapies practice, depression symptoms may decrease or remit as the client experiences increased self-acceptance and personal growth.
Why it is important to do this review
Clinical guidelines recommend cognitive behavioural therapy (CBT) and interpersonal therapy as first-line treatments for people with moderate to major depressive disorder (Ballenger 2001; NICE 2009 ) and counselling (which may include humanistic, psychodynamic, or cognitive behavioural approaches, applied discretely or integratively) for mild depression. The evidence-base for humanistic therapy approaches in the treatment of common mental disorders in general, and specifically in depressive disorders, is less extensive than for CBT-oriented therapies. Recent systematic reviews have been limited to person-centred/experiential therapies (Elliott 2009) Given that a high proportion of therapists and counsellors employed in UK primary care settings continue to use a person-centred approach (Stiles 2008) , comprehensive review and meta-analysis of currently available evidence is called for to ensure that as far as possible it successfully represents and informs future health care policy and clinical practice in the treatment of depressive disorders. Furthermore, acknowledging the diversity of approaches under the umbrella of humanistic psychological therapies, examination of the efficacy and comparative efficacy of differing humanistic therapy approaches for the treatment of depression is of considerable importance. This review forms part of a programme of 12 reviews covering behavioural, cognitive behavioural, psychodynamic, interpersonal, cognitive analytic and other integrative, humanistic and mindfulness-based 'third wave' cognitive and behavioural psychological therapies, all compared with treatment as usual or with one another.
O B J E C T I V E S
1. To examine the effectiveness and acceptability of all humanistic therapies compared with all other psychological therapy approaches for acute depression.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) will be eligible for inclusion in the review. Trials employing a cross-over design will be included in the review (whilst acknowledging that this design is rarely used in psychological therapy trials), using data from the first active treatment stage only. Cluster RCTs will also be eligible for inclusion. Quasi-randomised controlled trials, in which treatment assignment is decided through methods such as alternate days of the week, will not be eligible for inclusion.
Types of participants Participant characteristics
Studies of men and women aged ≥18 years will be included. A Cochrane review on psychotherapy for depression in children and adolescents (<18 years) has been undertaken separately and is soon to be published (Watanabe 2004) . The increasing prevalence of memory decline (Ivnik 1992), cognitive impairment (Rait 2005) and multiple comorbid physical disorders/polypharmacy (Chen 2001) in individuals over 74 years may differentially influence the process and effect of psychological therapy interventions. Therefore, to ensure that older patients are appropriately represented in the review (Bayer 2000; McMurdo 2005 ) an upper age cutoff of <75 years will be used (when a study may have included individuals ≥75, we will include it so long as the average age is <75), and a previously published Cochrane review on psychotherapeutic treatments for older depressed people (Wilson 2008) will be updated concurrently by the authors.
Setting
Studies may be conducted in primary care and community-based settings, or in secondary or specialist settings, and will include referrals as well as volunteers. Studies involving inpatients will be excluded. Studies that focus on specific populations -nurses, care givers, depressed participants at a specific work place -will be included if the participants all meet the criteria for depression.
Diagnosis
We will include all studies that focus on acute phase treatment of clinically diagnosed depression. 1. Studies adopting any standardised diagnostic criteria to define participants suffering from an acute phase unipolar depressive disorder will be included. Accepted diagnostic criteria include Feighner criteria, Research Diagnostic Criteria, DSM-III (APA 1980), DSM-III-R (APA 1987), DSM-IV-TR (APA 2000) or ICD-10 (WHO 1992) criteria. Earlier studies may have used ICD-9 ( WHO 1978), but ICD-9 is not based on operationalised criteria, so studies using ICD-9 will be excluded from this category.
2. Mild, moderate and severe depressive disorders are all found in primary care (Mitchell 2009; Roca 2009 ). In order to fully represent the broad spectrum of severity of depressive symptoms encountered by healthcare professionals in primary care, studies that used non-operationalised diagnostic criteria or used a validated clinician or self-report depression symptom questionnaire, such as Hamilton Rating Scale for Depression (Hamilton 1960) and Beck Depression Inventory (Beck 1961) , to identify depression caseness based on a recognised threshold, will also be included. However, the influence of including this category of studies will be examined in a sensitivity analysis. Accepted strategies for classifying mild, moderate and severe depression will be employed based, where possible, on those criteria used in the evidence syntheses underpinning the NICE 2009 guidelines for depression. Studies focusing on chronic depression or treatment resistant depression, i.e. studies that listed these conditions as inclusion criteria, will be excluded from the review. Studies in which participants are receiving treatment to prevent relapse following a depressive episode (that is, where participants are not depressed at study entry) will also be excluded. Studies of people described as 'at risk of suicide' or with dysthymia or other affective disorders such as panic disorder a will be included if the participants meet criteria for depression as stated above, but will be excluded if not. We will not include subgroup analyses of people with depression, selected out of people with mixed diagnoses, because such studies would be susceptible to publication bias (the authors reported such subgroup studies because the results were "interesting"). In other words we will include such studies only if the inclusion criteria for the entire study satisfied our eligibility criteria.
Comorbidity
Studies involving participants with comorbid physical or common mental disorders will be eligible for inclusion, as long as the comorbidity is not the focus of the study. In other words, we will exclude such studies which focused on depression among patients with Parkinson's disease or after acute myocardial infarction but will accept such studies which may have included some participants with Parkinson's disease or acute myocardial infarction.
Types of interventions Experimental intervention
The review recognises the overlap between different orientations (Sanders 2007 ) and the variations even within specific orientations, such as person-centred or gestalt therapy (Cooper 2008). Whilst acknowledging this variation and overlap, humanistic therapy approaches will be grouped into six main categories based on the theoretical principles set out by trial authors.
Person-centred therapy (Rogerian or client-centred therapy)
In person-centred therapy (PCT), core conditions of empathy, genuineness and unconditional positive regard, considered to be the 'antithesis' of a therapeutic technique (Cooper 2008) are considered sufficient to facilitate personality change . Use of a non-directive stance by the therapist is a key feature of PCT (Mearns 2007) . Moving through three phases of trust, intimacy and mutuality within the therapeutic relationship (Mearns 2007), change occurs as the client shifts from a negative evaluation of self towards a belief that they are worth caring for (Thorne 2002).
Gestalt therapy
Gestalt therapy focuses on the process of human contact, described as the contact or 'need cycle' (Strumpfel 2006) . The cycle begins with an emotional impulse and is completed when the need is gratified and assimilated. Disturbances to the contact cycle, such as the belief that 'I am not allowed to get angry', are seen as the basis of pathology and become the focus of therapy (Strumpfel 2006) . Gestalt therapists support and provoke exploration of disturbances within the 'here and now' experience of the therapeutic encounter, with the aim of resolving the disturbance and helping the client to complete the contact cycle. Originally conducted using a confrontational style (Perls 1976) , Gestalt therapy models have become 'softer' and more dialogue-based (Yontef 1998). Experiments remain a central tenet of Gestalt therapy approaches, through use of a range of techniques such as exaggeration (repeating and intensifying a particular behaviour to bring unconscious emotional processes into awareness), dramatising (assuming roles of influential people in clients' lives through staging family scenes), artwork, dance/other physical movement and two-chair/ empty chair work (exploration of conflict within the client) as part of the experiential learning process (Strumpfel 2006).
Experiential therapies
Experiential therapies, include focused-oriented psychotherapy (Gendlin 1996) and emotion-focused therapy, manualised as process-experiential therapy (Greenberg 2005). Focus-oriented psychotherapy integrates 'levels of interventiveness' techniques (the degree on which a therapist brings in material from outside the client's frame of reference, and the degree to which this is done from the stance of authority or expertise) (Warner 2000) with Rogers' therapeutic conditions to help clients to attend to their moment-by-moment experiencing, and so enhance insight and therapeutic change. Similarly, process-experiential therapy, still in development, uses techniques such as two-chair and empty chair dialogue, drawn from gestalt therapy and cognitive/information processing psychology to enable here and now experiencing of emotional processes (Sanders 2007) .
Transactional analysis
Whilst drawing from a broad range of influences, including psychodynamic, cognitive behavioural and existential theory, transactional analysis is considered essentially to be consistent with core beliefs of humanistic psychology theory and practice (Berne 1961; Tudor 2002) . The primary goal of transactional analysis is the creation of a meaningful working alliance, within which transformation and development can occur. Ego states, transactions, scripts and games are cornerstones of transactional analysis theory and practice, and these may be explored using eight sequential 'therapeutic operations' of interrogation, specification, confrontation, explanation, illustration, confirmation interpretation and crystallisation, once the working alliance has been established (Tudor 2002).
Existential therapy
Existential therapy is described as a rich tapestry of intersecting therapeutic practices, all of which orientate themselves around the shared concern of 'human lived existence ' (Cooper 2003) . In clinical practice, existential therapists have a preference for autonomous, individualised approaches with clients rather than a single all-encompassing system (Cooper 2003) . In Yalom's existential therapy (Yalom 1980) , clients are encouraged to confront four ultimate existential concerns of death, freedom, isolation and meaninglessness. In contrast, van Deurzen's approach explores four dimensions of worldly being, consisting of physical, personal, social and spiritual dimensions (van Deurzen 2002) . In other existential therapy approaches, practitioners work with clients to focus in on subjective experiences (Bugental 1978) or to focus out on their responsibilities to others (Frankl 1984).
Non-directive/supportive therapies
Therapies described as 'non-directive' or 'supportive', and not explicitly underpinned by humanistic theory, principles and supporting references, will be included in the review. The impact of their inclusion will be examined in sensitivity analyses (see Methods section).
Other humanistic therapies
Where studies of other humanistic therapy approaches not listed above are identified, a post-hoc decision will be made about their inclusion in the review, and the impact of their inclusion with be examined in a sensitivity analysis (see Methods section).
Comparators
The control comparison will be all other types of psychological therapies, categorised as psychodynamic, behavioural, integrative, cognitive behavioural and third wave CBT approaches.
Psychodynamic therapies
Grounded in psychoanalytic theory (Freud 1949) , psychodynamic therapy (PD) uses the therapeutic relationship to explore and resolve unconscious conflict, through transference and interpretation, with development of insight and circumscribed character change as therapeutic goals, and relief of symptomatology as an indirect outcome. Brief therapy models have been devised by Malan 1963 , Mann 1973 and Strupp 1984 .
Behavioural therapies
Building on Skinner's theory of depression as an interruption in established sequences of health behaviour positively reinforced by the social environment (Skinner 1953) , behavioural therapies focus attention on increasing access to pleasant events and positive reinforcers. The frequency of aversive events is decreased (Lewinsohn 1972) through monitoring of pleasant events, activity scheduling, social skills development and time management training (Hopko 2003).
Interpersonal, cognitive analytic and other integrative therapies
Integrative therapies are approaches that combine components of different psychological therapy models. Integrative therapy models include interpersonal therapy (IPT) (Klerman 1984), cognitive analytic therapy (CAT) (Ryle 1990) , and Hobson's conversational model (Hobson 1985) , manualised as psychodynamic interpersonal therapy (Shapiro 1990) . With its focus on the interpersonal context, IPT was developed in order to specify what was thought to be a set of helpful procedures commonly used in psychotherapy for depressed outpatients (Weissman 2007), drawing in part from attachment theory (Bowlby 1980) and cognitive behavioural therapy (www.interpersonalpsychotherapy.org, 9/9/09), within a time-limited framework. CAT, also devised as a time-limited psychotherapy, integrates components from cognitive and psychodynamic approaches. The conversational model integrates psychodynamic, interpersonal and person-centred model components. Counselling interventions traditionally draw from a wide range of psychological therapy models, including person-centred, psychodynamic and cognitive behavioural approaches, applied integratively, according to the theoretical orientation of practitioners (Stiles 2008) . Therefore, studies of counselling will usually be included in the integrative therapies reviews. However if the counselling intervention consists of a single discrete psychological therapy approach, it will be categorised as such, even if the intervention is referred to as 'counselling'. If the intervention is manualised, this will inform our classification.
Cognitive behavioural therapies
In cognitive behavioural therapy, therapists aim to work collaboratively with clients to understand the link between thoughts, feelings and behaviour, and to identify and modify unhelpful thinking patterns, underlying assumptions and idiosyncratic cognitive schema about the self, others and the world (Beck 1979). Cognitive change methods for depression are targeted at the automatic thought level in the first instance, and include thought catching, reality testing, task assignment and generating alterative strategies (Williams 1997) . Behavioural experiments are then used to reevaluate underlying beliefs and assumptions (Bennett-Levy 2004).
Mindfulness-based 'third wave' cognitive and behavioural therapies
Third wave CBT approaches conceptualise cognitive thought processes as a form of 'private behaviour' (Hayes 2006; Hofmann 2008) . Third wave CBT target the individual's relationship with cognitions and emotions, focusing primarily on the function of cognitions such as thought suppression or experiential avoidance (an attempt or desire to suppress unwanted internal experiences, such as emotions, thoughts, and bodily sensations) (Hofmann 2008) . A range of strategies, including mindfulness exercises, acceptance of unwanted thoughts and feelings, and cognitive diffusion (stepping back and seeing thoughts as just thoughts), are used to bring about change in the thinking process. Drawing from psychodynamic and humanistic principles, third wave CBT approaches also place great emphasis on use of the therapeutic relationship.
Format of psychological therapies
The psychological therapy intervention is required to be delivered through face to face meetings between the patient and therapist. Interventions in which face to face therapy is augmented by telephone or Internet-based support will be included in the review. Psychological therapy approaches conducted on either an individual or on a group basis will be eligible for inclusion. There is no limit to the number of sessions and we accept psychological therapy delivered in only one session.
Excluded interventions
Studies of long-term, continuation or maintenance therapy interventions designed to prevent relapse of depression or to treat chronic depressive disorders will be excluded from the review. Similarly studies of interventions designed to prevent a future episode of depression will be excluded. Guided self-help, in which the practitioner provides brief face to face non-therapeutic support to patients who are using a self-help psychological therapy intervention, will be excluded. Psychological therapy that is provided wholly by telephone or over the Internet will not be eligible for inclusion. Studies of dual modality treatments, in which patients are randomised to receive a humanistic therapy intervention combined with pharmacological treatment and compared with a treatment as usual control condition, will be excluded from the current review, and will be examined in a separate programme of reviews on combination treatments for depression. Component or dismantling studies, in which the effectiveness of individual components of a humanistic therapeutic approach are investigated, will not be included. Data from these studies will be extracted and included in a separate overview of psychological therapies for depression, in which multiple treatments meta-analysis (MTM) will be used to compare the relative effectiveness of all psychotherapies, regardless of whether they have been directly compared in direct RCTs. If there is sufficient data, we will use the MTM model proposed in Welton 2009 to allow conclusions to be drawn regarding which components, or combination of components, are most effective at reducing depressive symptoms. See Unit of analysis issues for further detail on MTM. Psychological therapy models based on social constructionist principles (that focus on the ways in which individuals and groups participate in the construction of their perceived social reality) including couples therapy, family therapy, solution-focused therapy, narrative therapy, personal construct therapy, neuro-linguistic programming and brief problem-solving (Watzlavick 1974) will be excluded. These therapies work with patterns and dynamics of relating within and between family, social and cultural systems in order to create a socially constructed framework of ideas , rather than focusing on one individual's reality. Previously published Cochrane reviews on couples therapy for depression (Barbato 2006) and family therapy for depression (Henken 2007) will be updated concurrently. Where the description of an intervention suggests it does not meet the inclusion criteria for an active psychological therapy approach, that study/study arm will be excluded from this review. If the intervention involved significant time spent with the patient, the review team will take a post hoc decision about whether it should be included as an attention placebo/control in a linked review on humanistic therapies versus treatment as usual for depression. (Montgomery 1979) , or any other validated depression scale. Many studies define response by 50% or greater reduction on BDI, HAM-D etc. but some studies define response using Jacobson's Reliable Change Index; we will accept the study authors' original definition. If the original authors report several outcomes corresponding with our definition of response, we will give preference to BDI for selfrating scale and HAM-D for observer-rating scale.
Types of outcome measures
2. Treatment acceptability: the number of participants who drop out of psychological therapy treatment for any reason. Examples of definitions of remission include 10 or less on BDI, 7 or less on HAM-D or 10 or less on MADRS; we will accept the study authors' original definition. If the original authors report several outcomes corresponding with our definition of response, we will give preference to BDI for self-rating scale and HAM-D for observer-rating scale.
2. Improvement in depression symptoms, based on a continuous outcome of group mean scores at the end of treatment using BDI, HAM-D, MADRS, or any other validated depression scale.
3. Improvement in overall symptoms, using the Clinical Global Impressions Scale (CGI) (Guy 1976).
4. Improvement in anxiety symptoms, measured using a validated continuous scale, either assessor-rated, such as the Hamilton Anxiety Scale [HAM-A] (Hamilton 1959) or selfreport, including the Trait subscale of the Spielberger State-Trait Anxiety Inventory (STAI-T) (Spielberger 1983 ) and the Beck Anxiety Inventory (BAI) (Beck 1988).
5. Adverse effects, such as completed suicides, attempted suicides and worsening of symptoms, where reported, will be summarised in narrative form.
6. Social adjustment, social functioning including the Global Assessment of Function (Luborsky 1962) scores, where reported, will be summarised in narrative form.
7. Quality of life, using validated measures such as the SF-36 (Ware 1993), HoNOS (Wing 1994) and WHOQOL (WHOQL 1998) , where reported, will be summarised in narrative form.
8. Economic outcomes (e.g. days of work absence/ability to return to work, number of appointments with primary care physician, number of referrals to secondary services, use of additional treatments) where reported, will be summarised in narrative form.
Search methods for identification of studies Electronic searches CCDANCTR Registers
We will search two clinical trials registers created and maintained by the Cochrane Depression, Anxiety and Neurosis Group (CCDAN), the CCDANCTR-Studies Register and the CC-DANCTR-References Register. References to trials for inclusion in the Group's registers are collated from routine (weekly) searches of MEDLINE, EMBASE and PsycINFO, quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL) and additional ad hoc searches of other databases (PSYNDEX, LILACS, AMED, CINAHL). These searches employ generic terms for depression anxiety and neuroses; together with sensitive (database specific) RCT filters.
References to trials are also sourced from international trials registers via the World Health Organisation's trials portal (http:// apps.who.int/trialsearch/); drug companies; the hand-searching of key journals, conference proceedings and other (non-Cochrane) systematic reviews and meta-analyses.
Details of the generic search strategies can be found in the 'Specialized Register' section of the Cochrane Depression, Anxiety and Neurosis Group's module text.
The CCDANCTR-Studies Register
The CCDANCTR-Studies Register contains over 11,000 trials for the treatment or prevention of depression, anxiety and neurosis. Each trial has been coded using the EU-Psi coding manual (as a guide) and includes information on intervention, condition, comorbidities, age, treatment setting etc. The studies register will be searched using the following search terms: Condition = (depress* or dysthymi*) and Intervention = (*therap* or training)
The CCDANCTR-References Register
The CCDANCTR-References Register contains bibliographic records of reports of trials coded in the CCDANCTR-Studies Register together with several other uncoded references (total number of records=24,500). This register will be searched using a comprehensive list of terms for 'psychotherapies' as indicated in Appendix 1. Records already retrieved from the search of the CCDANCTRStudies Register will be de-duplicated.
Searching other resources 1. Reference lists
The references of all selected studies will be searched for more published reports and citations of unpublished studies. Relevant review papers will be checked.
Personal communication
Subject experts will be contacted to check that all relevant studies, either published or unpublished, have been considered for inclusion.
Data collection and analysis

Selection of studies
Two review authors (RC and VH) will examine the abstracts of all publications obtained through the search strategy. Full articles of all the studies identified by either of the review authors will then be obtained and inspected by the same two review authors for trials meeting the following criteria:
1. Randomised controlled trial; 2. Participants have depression diagnosed by operationalised criteria; and 3. Any humanistic therapy approach, to include supportive or non-directive placebo control therapies, compared with any other psychological therapy approach. Conflicts of opinion regarding eligibility of a study will be discussed with a third review author, having retrieved the full paper and consulted the authors if necessary, until consensus is reached. External subject or methodological experts will be consulted if necessary.
Data extraction and management
Data will be extracted by two review authors, with data from each study being extracted independently by two of these authors. Any disagreement will be discussed with an additional review author and where necessary, the authors of the studies will be contacted for further information. Information relating to study population, sample size, interventions, comparators, potential biases in the conduct of the trial, outcomes including adverse events, follow-up and methods of statistical analysis will be abstracted from the original reports into specially designed paper forms then entered into a spreadsheet.
Management of time points
Post-treatment outcomes and outcomes at each reported followup point will be summarised. Where appropriate and if the data allow, outcomes will be categorised as short term (up to 6 months post-treatment), medium term (7 to 12 months post-treatment) long term (longer than 12 months).
Assessment of risk of bias in included studies
Risk of bias will be assessed for each included study using the Cochrane Collaboration 'risk of bias' tool (Higgins 2008a). The following six domains will be considered:
1. Sequence generation: Was the allocation sequence adequately generated?
2. Allocation concealment: Was allocation adequately concealed?
3. Blinding of participants, personnel and outcome assessors for each main outcome or class of outcomes: Was knowledge of the allocated treatment adequately prevented during the study?
4. Incomplete outcome data for each main outcome or class of outcomes: Were incomplete outcome data adequately addressed?
5. Selective outcome reporting: Are reports of the study free of suggestion of selective outcome reporting?
6. Other sources of bias: Was the study apparently free of other problems that could put it at a high risk of bias? Additional items to be included here are therapist qualifications, treatment fidelity and researcher allegiance/conflict of interest.
A description of what was reported to have happened in each study will be provided, and a judgement on the risk of bias will be made for each domain within and across studies, based on the following three categories: A. Yes (low risk of bias) B. Unclear C. No (high risk of bias). Two independent review authors will assess the risk of bias in selected studies. Any disagreement will be discussed with a third review author. Where necessary, the authors of the studies will be contacted for further information. All risk of bias data will be presented graphically and described in the text. Allocation concealment will be used as a marker of trial quality for the purposes of undertaking sensitivity analyses.
Measures of treatment effect
Continuous outcomes: where studies have used the same outcome measure for comparison, data will be pooled by calculating the mean difference (MD). Where different measures are used to assess the same outcome , data will be pooled with standardised mean difference (SMD) and 95% confidence intervals calculated. Dichotomous outcomes: these outcomes will be analysed by calculating a pooled odds ratio (OR) and 95% confidence intervals for each comparison. Because ORs can be difficult to interpret, these pooled ORs will be converted to relative risks (RR) using the formula provided in The Cochrane Handbook (Higgins 2008a) and presented in this form for ease of interpretation.
Unit of analysis issues
Multiple-arm studies (those with greater than two intervention arms) can pose analytical problems in pair-wise meta-analysis. For studies with more than two relevant active treatment arms data will be managed in this review as follows:
Continuous data
Means, SDs and number of participants for each active treatment group will be pooled across treatment arms as a function of the number of participants in each arm to be compared against the control group (Law 2003; Higgins 2008a; Higgins 2008c) .
Dichotomous data
Data from relevant active intervention arms will be collapsed into a single arm for comparison or data from relevant active intervention arms will be split equally between comparator arms.
Multiple treatment meta-analysis
One method which retains the individual identity of each intervention and allows multiple intervention comparisons to be made, without the need to lump or split intervention arms, is a multiple treatment meta-analysis (MTM) (Lu 2004; Caldwell 2005; Cipriani 2009c) . MTM (also known as Mixed Treatment Comparison or Network Meta-analysis) refers to ensembles of trial evidence in which direct and indirect evidence on relative treatment effects are pooled. The objective of an MTM analysis is to combine all the available trial evidence into an internally consistent set of estimates while respecting the randomisation in the evidence. An MTM provides estimates of the effect of each intervention relative to every other, whether or not they have been directly compared in trials. One can also calculate the probability that each treatment is the most effective. We do not intend to use an MTM in this review, as we are unlikely to have sufficient data for the analysis. However, this review forms part of a series of 12 reviews which will contribute studies to an overview of reviews (Higgins 2008b; Becker 2009) in which MTM will be used as the main analytical strategy.
Dealing with missing data
Missing dichotomous data will be managed through intention to treat (ITT) analysis, in which it will be assumed that patients who dropped out after randomisation had a negative outcome. Best / worse case scenarios will also be calculated for the clinical response outcome, in which it will be assumed that dropouts in the active treatment group had positive outcomes and those in the control group had negative outcomes (best case scenario), and that dropouts in the active treatment group had negative outcomes and those in the control group had positive outcomes (worst case scenario), thus providing boundaries for the observed treatment effect. If there is a large amount of missing information then these best / worst case scenarios will be given greater emphasis in the presentation of the results. Missing continuous data will either analysed on an endpoint basis, including only participants with a final assessment, or analysed using last observation carried forward to the final assessment (LOCF) if LOCF data were reported by the trial authors. Where SDs are missing, attempts will be made to obtain these data through contacting trial authors. Where SDs are not available from trial authors, they will be calculated from P values, t-values, confidence intervals or standard errors, where reported in articles (Deeks 1997).
Where the vast majority of actual SDs are available and only a minority of SDs are unavailable or unobtainable, a method used for imputing SDs and calculating percentage responders devised by Furukawa and colleagues (Furukawa 2005; Furukawa 2006) will be used. Where this method is employed, data will be interpreted with caution, taking account of the degree of heterogeneity observed. A sensitivity analysis will also be undertaken to examine the effect of the decision to use imputed data. Where additional figures are not available or obtainable, and it is not deemed appropriate to use the Furukawa method described above, the study data will not be included in the comparison of interest.
Assessment of heterogeneity
Statistical heterogeneity will be formally tested using the chi 2 test, which provides evidence of variation in effect estimates beyond that of chance. Since the chi 2 test has low power to assess heterogeneity where a small number of participants or trials are included, the P value will be conservatively set at 0.1. Heterogeneity will also be quantified using the I 2 statistic, which calculates the percentage of variability due to heterogeneity rather than chance. We expect, a priori, that there will be considerable clinical heterogeneity between studies and so I 2 values in the range of 50% to 90% will be considered to represent substantial statistical heterogeneity and will be explored further. However, the importance of the observed I 2 will depend on the magnitude and direction of treatment effects and the strength of evidence for heterogeneity (Higgins 2003; Deeks 2009 ). Forest plots generated in RevMan 5 now also provide an estimate of tau 2 , the between-study vari-ance in a random-effects meta-analysis. To give an indication of the spread of true intervention effects we will use the tau 2 estimate to form an approximate range of intervention effects using the method outlined in section 9.5.4 of the Cochrane Handbook for Systematic Reviews of Interventions (Deeks 2009 ). This will be undertaken for the primary outcomes only.
Assessment of reporting biases
As far as possible, the impact of reporting biases will be minimised by undertaking comprehensive searches of multiple sources (including trial registries), increasing efforts to identify unpublished material, and including non-English language publications. We will also try and identify outcome reporting bias in trials by recording all trial outcomes, planned and reported and noting where there are missing outcomes. Where we find evidence of missing outcomes, we will attempt to obtain any available data direct from the authors. Where sufficient numbers of trials allow for a meaningful analysis, funnel plots will be constructed to establish the potential influence of reporting biases and small study effects.
Data synthesis
Given the potential heterogeneity of psychological therapy approaches for inclusion, together with the likelihood of differing secondary comorbid mental disorders in the population of interest, a random-effects model will be used in all analyses.
Subgroup analysis and investigation of heterogeneity
Clinical heterogeneity 1. Baseline depression severity: the severity of depression on entering the trial is expected to have an impact on outcomes. Heterogeneity analyses will categorise baseline severity as mild, moderate or severe.
2. Number of sessions: there are likely to be differences in the numbers of therapy sessions received and this is expected to affect treatment outcome. Numbers of sessions will be categorised as 1 to 7 sessions, 8 to 12 sessions, 13 to 20 sessions and more than 20 sessions.
3. Type of comparison: the type of comparator used is likely to influence the observed effectiveness of the intervention. Where possible, comparators will be categorised according as psychodynamic, BT, integrative, CBT and third wave CBT.
4. Strength of therapeutic alliance/perceived therapist empathy, based on validated measures such as the BarrettLennard Relationship Inventory (Barrett-Lennard 1986) or Working Alliance Inventory (Horvath 1986): where reported, this information will be summarised in narrative form.
Sensitivity analysis
1. Fidelity to treatment: studies that have not assessed fidelity to the psychological therapy model(s) under evaluation through assessment of audio or videotapes of therapy sessions will be excluded 2. Study quality: allocation concealment will be used as a marker of trial quality. Studies that have not used allocation concealment will be excluded.
3. Trials where missing data has been imputed will be excluded.
4. Antidepressant treatment (naturalistic use; combination treatment used in both psychological therapy arms) 5. Trials included in the review following post-hoc decisions about their eligibility as following humanistic therapeutic approaches will be excluded.
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